XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.3

Long-Term Investments (Details) - Schedule of Extent the Investee Relies	9 Months Ended
	Sep. 30, 2024
Braingenesis Biotechnology Co., Ltd. [Member]
Schedule of Extent the Investee Relies [Line Items]
The extent the investee relies on the Company for its business, description	No specific business relationship
Genepharm Biotech Corporation [Member]
Schedule of Extent the Investee Relies [Line Items]
The extent the investee relies on the Company for its business, description	No specific business relationship
BioHopeKing Corporation [Member]
Schedule of Extent the Investee Relies [Line Items]
The extent the investee relies on the Company for its business, description	Collaborating with the Company to develop and commercialize drugs
ForSeeCon Corporation [Member]
Schedule of Extent the Investee Relies [Line Items]
The extent the investee relies on the Company for its business, description	Collaborating with the Company to develop and commercialize ophthalmic medical devices (referring to Note 4, Collaborative Agreements)
OncoX BioPharma, Inc. [Member]
Schedule of Extent the Investee Relies [Line Items]
The extent the investee relies on the Company for its business, description	Collaborating with the Company to develop and commercialize single-herb botanical drug for treatment of certain diseases (referring to Note 4, Collaborative Agreements)
BioFirst Corporation [Member]
Schedule of Extent the Investee Relies [Line Items]
The extent the investee relies on the Company for its business, description	Loaned from investee and provides research and development support service
Rgene Corporation [Member]
Schedule of Extent the Investee Relies [Line Items]
The extent the investee relies on the Company for its business, description	Collaborating with the Company to develop and commercialize drugs
BioLite Japan K.K. [Member]
Schedule of Extent the Investee Relies [Line Items]
The extent the investee relies on the Company for its business, description	Prepaid investment for a Joint Venture

X

- Definition

A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 840
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481440/840-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478964/842-20-50-7

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479773/842-30-50-4

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479741/842-40-50-1

+ Details

Name:	us-gaap_RelatedPartyTransactionDescriptionOfTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BraingenesisBiotechnologyCoLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_GenepharmBiotechCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioHopeKingCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_ForSeeConCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_OncoXBioPharmaIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioFirstCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_RgeneCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioLiteJapanKKMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: